SharpLight OmniMax S4
IPL multi-app platform · DPC pulsed light + Nd:YAG + RF
Technology: Nd:YAG Laser
Classification & configurations
Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)
At a glance
- New price
- $60k–$90kSource not documented
- Used asking price
- $25k–$45kSource not documented
- FDA status
- Supplies & recurring costs
- Supply details not yet documented.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- FDA
- FDA ClearedK233304
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 1 FDA record
K233304 (Sharplight Technologies, Ltd., 2023)
The Omnimax Device Series along with its optional Handpieces, uses IPL, IR, Laser and RF technologies and is intended for use in aesthetic and cosmetic applications and in selective treatments in medical specialties of dermatology, through the transmission of energy to human skin. Intense Pulsed Light (IPL-DPC) with 415 – 1200 nm wavelengths (with and without contact-cooling) handpieces are indicated for: • Hair removal and Permanent Hair Reduction in all skin types (I-V) to the Fitzpatrick scale – Recommended wavelengths in the range of 635-950 nm, 730-950 nm or 580-950 nm. • Flow Mode is suitable for Fitzpatrick skin types I-VI. Recommended wavelength: 635nm-950nm. • Treatment of Benign Pigmented Epidermal and Cutaneous Lesions including warts, scars and striae in all skin types (I-VI) to the Fitzpatrick scale – Recommended wavelength in the range of 580-950 nm. • Treatment of Pigmented and Vascular Lesions in all skin types (I-VI) to the Fitzpatrick scale – Recommended wavelength in the range of 535-950 nm. • Treatment of Benign Pigmented Epidermal, Cutaneous and Vascular Lesions including warts, scars and striae in skin types (I-V) to the Fitzpatrick scale – Recommended wavelength in the range of 535-680 nm & 860-1200nm. • Treatment of Inflammatory Acne (acne vulgaris) in skin types (I-V) to the Fitzpatrick scale – Recommended wavelength in the range of 415-950 nm. Infrared (IR) with 850 – 1750 nm wavelengths (with contact cooling) handpieces is indicated for: • Dermatologic Treatment such as, but not limited to: photocoagulation of soft tissue (Scars, Wrinkles, Rhytids and Periorbital Wrinkles). […]
Excerpt — verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026; "[…]" marks text omitted from the source.
Page updated: September 4, 2026 · How we verify
Axis runs $0–$90k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | SharpLight |
|---|---|
| Company | Not published |
| Parent company | SharpLight |
| Brand owner | SharpLight |
| Built by (OEM) | SharpLight Technologies |
| Category | IPL multi-app platform |
| Technology | DPC pulsed light + Nd:YAG + RF |
| FDA status | FDA Cleared |
| 510(k) citation | K233304 |
| New price range | $60k–$90k |
| Used asking range | $25k–$45k |
| Consumables | Not published |
| Launch year | 2016 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Multi-technology HR/photofacial station
FDA & regulatory detailClearance timeline, authorization route and citation notes
510(k): K233304 (Omnimax S3, Omnimax S4, SharpLight, decision 22 Dec 2023). Checked 4 Sep 2026.
FDA-cleared indications (verbatim)
K233304 (Sharplight Technologies, Ltd., 2023)
The Omnimax Device Series along with its optional Handpieces, uses IPL, IR, Laser and RF technologies and is intended for use in aesthetic and cosmetic applications and in selective treatments in medical specialties of dermatology, through the transmission of energy to human skin. Intense Pulsed Light (IPL-DPC) with 415 – 1200 nm wavelengths (with and without contact-cooling) handpieces are indicated for: • Hair removal and Permanent Hair Reduction in all skin types (I-V) to the Fitzpatrick scale – Recommended wavelengths in the range of 635-950 nm, 730-950 nm or 580-950 nm. • Flow Mode is suitable for Fitzpatrick skin types I-VI. Recommended wavelength: 635nm-950nm. • Treatment of Benign Pigmented Epidermal and Cutaneous Lesions including warts, scars and striae in all skin types (I-VI) to the Fitzpatrick scale – Recommended wavelength in the range of 580-950 nm. • Treatment of Pigmented and Vascular Lesions in all skin types (I-VI) to the Fitzpatrick scale – Recommended wavelength in the range of 535-950 nm. • Treatment of Benign Pigmented Epidermal, Cutaneous and Vascular Lesions including warts, scars and striae in skin types (I-V) to the Fitzpatrick scale – Recommended wavelength in the range of 535-680 nm & 860-1200nm. • Treatment of Inflammatory Acne (acne vulgaris) in skin types (I-V) to the Fitzpatrick scale – Recommended wavelength in the range of 415-950 nm. Infrared (IR) with 850 – 1750 nm wavelengths (with contact cooling) handpieces is indicated for: • Dermatologic Treatment such as, but not limited to: photocoagulation of soft tissue (Scars, Wrinkles, Rhytids and Periorbital Wrinkles). […]
Excerpt — verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026; "[…]" marks text omitted from the source.
Marketed for
Nd:YAG — DPC pulsed light + Nd:YAG + RF
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: SharpLight
Legal manufacturer: SharpLight Technologies (Canada)
Applicant on the FDA record
SharpLight TechnologiesThe applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Consumable costs are not documented yet.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published SharpLight OmniMax S4 data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History4 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 4, 2026
510(k) numbers
K-number set re-verified against openFDA
Source: Council round 2 audit, verified on openFDA 2026-09-04
September 4, 2026
FDA K-numbers
Source: Catalog update
September 4, 2026
FDA source URL
Source: Catalog update
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "SharpLight OmniMax S4 — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.